Clinical trial / 2001
Lactobacillus rhamnosus HN001 consumption increased cellular immune responses in older adults
In a three-stage trial of 52 healthy middle-aged and elderly volunteers, consuming 10^9 CFUs/g of Lactobacillus rhamnosus HN001 in milk for 3 weeks increased polymorphonuclear cell phagocytic activity by 19% in regular low-fat milk and 15% in lactose-hydrolyzed milk. Natural killer cell tumor killing activity also rose by 71% and 147%, respectively. Responses were not altered during the milk-only run-in period.
- Study type
- Pre-post intervention trial
- Who was studied
- 52 healthy volunteers aged 44-80, Taiwan
- What was measured
- Polymorphonuclear leukocyte phagocytic activity and natural killer cell tumoricidal activity
THE PAPER
Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001.
Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS. J Am Coll Nutr, 2001.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.